Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
Authors
Keywords
-
Journal
Journal of Diabetes Investigation
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-01-25
DOI
10.1111/jdi.13014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between statin use and physical function among community-dwelling older Japanese adults
- (2017) Hisashi Kawai et al. Geriatrics & Gerontology International
- Differential Characteristics of Skeletal Muscle in Community-Dwelling Older Adults
- (2017) Minoru Yamada et al. Journal of the American Medical Directors Association
- The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function
- (2016) Hans Drenth et al. European Review of Aging and Physical Activity
- Recent Advances in Sarcopenia Research in Asia: 2016 Update From the Asian Working Group for Sarcopenia
- (2016) Liang-Kung Chen et al. Journal of the American Medical Directors Association
- Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes
- (2016) Hiroyasu Mori et al. Journal of Diabetes Investigation
- Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly
- (2016) Taotao Wang et al. Scientific Reports
- Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway
- (2015) Chen-Yuan Chiu et al. JOURNAL OF PATHOLOGY
- Sarcopenia and falls in community-dwelling elderly subjects in Japan: Defining sarcopenia according to criteria of the European Working Group on Sarcopenia in Older People
- (2014) Yoshimi Tanimoto et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Hyperglycemia Predicts Persistently Lower Muscle Strength With Aging
- (2014) Rita Rastogi Kalyani et al. DIABETES CARE
- Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
- (2014) Liang-Kung Chen et al. Journal of the American Medical Directors Association
- Skin Autofluorescence Reflects Integration of Past Long-Term Glycemic Control in Patients With Type 1 Diabetes
- (2013) E. Sugisawa et al. DIABETES CARE
- Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population
- (2011) Carolina H.Y. Ling et al. CLINICAL NUTRITION
- Sarcopenia != Dynapenia
- (2011) B. C. Clark et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Dynapenia and Aging: An Update
- (2011) Todd M. Manini et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
- (2010) A. J. Cruz-Jentoft et al. AGE AND AGEING
- Skin advanced glycation end product accumulation and muscle strength among adult men
- (2010) Haruki Momma et al. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
- Revised Equations for Estimated GFR From Serum Creatinine in Japan
- (2009) Seiichi Matsuo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
- (2009) S. W. Park et al. DIABETES CARE
- Weight Increase Is Associated with Skeletal Muscle Immunostaining for Advanced Glycation End Products, Receptor for Advanced Glycation End Products, and Oxidation Injury
- (2008) Maria Pia de la Maza et al. REJUVENATION RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started